FDA NDC Directory · JSON-LD · Markdown

Deferasirox

NDC 62332-324 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210060
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsDEFERASIROX (125 mg/1)
Marketing started20191121
Package count1

External sources

Source: openFDA. Public-domain (CC0).